PathoVax, a Johns Hopkins–born startup developing a vaccine for human papillomavirus virus (HPV), raised $2.75 million in new funding, cofounder Joshua Wang said.
{iframe}https://technical.ly/baltimore/2018/10/18/jhu-startup-pathovax-raises-2-75m-grows-team/{/iframe}